glp-1 drug market competition 2025 Receptor Agonist Size & Trends 2035 How to Invest in GLP-1
Description
GLP-1 receptor agonists are injectable (or oral for semaglutide tablets) and may produce greater weight loss, whilst SGLT2 inhibitors are oral and work by increasing glucose excretion in urine
10.1093/ckj/sfaa198 [DOI] [PMC free article] [PubMed] [Google Scholar] 11
Which GLP-1 RAs are currently available
Weight loss is not only about the number on the scale
[DOI] [PubMed] [Google Scholar] 3.Lund P
Pozzilli et al., 2017
